Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17297503 | 0.92 | GPR3 (0.38) | ALDH1A1MAPTHPGDSMN1; SMN2RAB9A | |
| SCHEMBL17297530 | 0.87 | ADK (0.36) | ALDH1A1MAPTHPGDSMN1; SMN2ADK | |
| SCHEMBL17297623 | 0.86 | ADK (0.37) | ALDH1A1MAPTHPGDSMN1; SMN2RAB9A | |
| SCHEMBL19106545 | 0.86 | ADK (0.33) | ALDH1A1MAPTHPGDSMN1; SMN2ADK | |
| SCHEMBL19106542 | 0.85 | KDM4E (0.37) | ALDH1A1MAPTHPGDSMN1; SMN2GPR3 | |
| SCHEMBL19106536 | 0.85 | ALDH1A1 (0.37) | ALDH1A1MAPTHPGDSMN1; SMN2ADK | |
| SCHEMBL17297356 | 0.85 | KDM4E (0.45) | ALDH1A1MAPTHPGDSMN1; SMN2GPR3 | |
| SCHEMBL19106534 | 0.85 | KDM4E (0.45) | ALDH1A1MAPTHPGDSMN1; SMN2GPR3 | |
| SCHEMBL17297357 | 0.84 | KDM4E (0.47) | ALDH1A1MAPTHPGDSMN1; SMN2GPR3 | |
| SCHEMBL17297483 | 0.84 | ALDH1A1 (0.36) | ALDH1A1MAPTHPGDSMN1; SMN2ADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-12 | — | — | US | disclosed |
| US-10934308-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2021-03-02 | — | — | US | disclosed |
| WO-2017048025-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2017-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, TMEM109 | ALDH1A1 540/4885MAPT 2896/4885HPGD 3589/4885 |
| US-10934308-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device comprising same | OR51E2, NFE2L2, ETV6 | ALDH1A1 814/4885MAPT 1002/4885HPGD 3573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.